PTO Grants More Reviews of Herceptin Patents After Hospira Challenges

The PTO’s Patent Trial and Appeal Board will evaluate the validity of three Genentech patents covering its blockbuster breast cancer treatment Herceptin, following petitions for inter partes review filed by Hospira.
Source: Generic Line